Business Wire

Project Management Institute Launches Initial Products in Industry’s First Platform-Agnostic Suite of Resources to Accelerate Adoption of Citizen Development at Scale

21.10.2020 16:00:00 EEST | Business Wire | Press release

Share

Project Management Institute (PMI), the world’s leading association for the project management profession, today launched the industry’s first, platform-agnostic educational resources for organizations seeking to implement and scale Citizen Development (CD) practices. The first two products in a planned suite of offerings are available now:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201021005531/en/

  • The PMI Citizen Development Body of Knowledge (CDBOK™) is a centralized resource that will help individuals and enterprises understand best practices for implementing citizen development within an organization at scale.
  • The foundational training course is an e-learning training program that provides an introduction to citizen development and outlines best practices in CD methodologies.

Citizen development platforms use intuitive “low-code” and “no-code” tools, so that even non-technical, non-specialist employees can create apps, software solutions and even enterprise-grade applications without having to learn to code. The emergence of citizen development promises to improve enterprise productivity by making application and software development significantly faster and less costly, while also accelerating value delivery and enabling organizations to achieve outcomes more quickly.

“PMI is ideally positioned to help drive adoption of citizen development,” says Sunil Prashara, PMI President and CEO. “As the world’s leading not-for-profit association for the project management profession, we’ve spent the past 50 years equipping our stakeholders with the most relevant skills and resources so they can deliver change and business value, all to help their organizations succeed. To ensure we are providing the right tools for citizen development, we have tapped leading experts in the field and combined their knowledge and expertise with our own deep experience developing global standards and certification training for project managers all around the world. With more than 600,000 members and 1.5 million gross credential holders in nearly every country, we can serve as an objective resource for organizations and individuals looking to apply citizen development tools and methodologies thoughtfully and with confidence.”

Citizen Development Helps Pave the Way for the Next Wave of Business Transformation

Citizen development should ease the burden on over-taxed IT departments straining to cope with growing demands for support from business units. Forrester Research estimates that by 2024 the U.S. will have a deficit of 500,000 software developers.

“Citizen development will form the next wave of business transformation,” says Mr. Prashara. “Technological advances such as AI are eliminating much of the complexity involved in software development, allowing non-specialists to create their own solutions and bring new products and services to market in unprecedented timeframes. This will democratize software development and turbocharge digital transformation efforts.”

Citizen development enables a “hyper-agile” way of working, which can lead to substantial reductions in cost and development times. With citizen development, the speed at which you can take an idea and design, build, test and deploy apps enables teams and organizations to deliver projects and bring products and services to market faster than ever before.

Scaling Citizen Development at the Enterprise Level, Safely and Securely with PMI

Gartner estimates that the number of active citizen developers will be four times that of professional developers by 2023. PMI’s new suite of products should help facilitate that transition, allowing organizations to promote citizen development among their employees in a measured and secure way.

According to Gartner, 41 percent of business leaders report having active citizen development initiatives underway, with 20 percent either evaluating or planning to start CD initiatives. However, to derive maximum benefit from citizen development, organizations will need to scale it across the enterprise, creating an organizational operating system. There is an urgent need to enable this level of scalability in order to drive transformation efforts, Mr. Prashara says, and that was the driving force behind developing the new PMI offerings.

“PMI recognizes the critical role that citizen development plays in empowering individuals and organizations,” Mr. Prashara says. “As organizations look to leverage citizen development in their digital transformation programs, there are many pitfalls to avoid, including the lack of a comprehensive methodology and framework and adequate training to allow citizen developers to succeed. PMI is addressing this gap by providing a vendor-agnostic framework to support professionals’ need to learn the basics and best practices, but also organizations’ need to unlock the potential of citizen development in compliance with IT governance and security. This will give IT the confidence to scale citizen development across the enterprise to accelerate the organization’s transformation efforts.”

PMI Citizen Developer Products & Experiences in the Pipeline

While the initial offerings are available now, PMI will launch additional PMI Citizen Developer products in the coming months, to include specific role-based courses and certifications, as well as a community portal for sharing CD information and thought leadership. The PMI Citizen Development Body of Knowledge (CDBOK™) will also be followed by an executive book on CD best practices, highlighting specific case studies and leadership perspectives.

To learn how to unlock the potential of citizen development at your organization, go to: pmi.org/citizen-developer.

About Project Management Institute (PMI)

Project Management Institute (PMI) is the world's leading association for those who consider project, program or portfolio management their profession. Through global advocacy, collaboration, education and research, we work to prepare more than three million professionals around the world for The Project Economy: the coming economy in which work, and individuals, are organized around projects, products, programs and value streams. Now 50 years in the making, we work in nearly every country around the world to advance careers, improve organizational success and further mature the project management profession through globally-recognized standards, certifications, communities, resources, tools, academic research, publications, professional development courses and networking opportunities. As part of the PMI family, ProjectManagement.com® interactive website creates online global communities that deliver more resources, better tools, larger networks and broader perspectives. Visit us at www.PMI.org, www.projectmanagement.com, www.facebook.com/PMInstitute and on Twitter @PMInstitute.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Rachael Ballard
Rachael.ballard@pmi.org
443-618-7014

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy8.6.2026 13:00:00 EEST | Press release

Shilpa Biocare Pvt Ltd, a Subsidiary of Shilpa Medicare Limited (BSE/NSE: SHILPAMED) has entered a strategic equity partnership with Gate2Brain, S.L., a biotechnology company focused on CNS therapeutics. Shilpa becomes a strategic shareholder and CMC, manufacturing, and regulatory partner for G2B-002 — Gate2Brain's lead program targeting deadly pediatric brain cancers, DIPG and pGBM, both with Orphan Drug Designation from the US FDA and EMA. G2B-002 uses Gate2Brain's proprietary MiniAp4 peptide shuttle to deliver SN-38 across the blood-brain barrier, demonstrating up to 100-fold greater brain drug transport preclinically. First-in-human trials are anticipated by FY28. G2B-002 targets high-growth oncology markets — the glioblastoma market projected at USD 6.48B by 2035 (CAGR: 7.97%), pediatric brain tumors at USD 2.47B by 2031 (CAGR: 6.9%), and DIPG at USD 1.2B by 2035 (CAGR: 7.1%). Gate2Brain's MiniAp4 platform further extends potential across rare pediatric cancers and broader CNS cat

Haleon Invests in India to Deliver Better Everyday Health to Rural Communities8.6.2026 12:11:00 EEST | Press release

Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets and key to Haleon delivering its strategy and ambitions to reach one billion more consumers by 2030. Haleon will invest approximately £175 million2 in building a new oral health manufacturing site in Madhya Pradesh, central India and accelerate distribution efforts in rural India to meet rising demand. The new site will also support supply for wider Asia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608753094/en/ Haleon Health Ambassador on motorbike, equipped with testing kits, samples and diagnostic tools Building capacity to meet rising demand The new site, which is well-positioned in the middle of the country and close to some of India’s most renowned technical colleges, marks an important step in the delivery of Haleon’s Win as One strategy. Win as On

Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-18.6.2026 11:56:00 EEST | Press release

Diabetology Limited (Jersey) poster presentation (https://diabetology.co.uk/ada-poster) 1724-P at the ADA 86th Scientific Session, New Orleans, reporting first human data from Oraglutide™ — small capsule intestinally-released oral semaglutide, formulated using the proprietary Axcess™ delivery technology. KEY HIGHLIGHTS 6-day glucose control: A single 4 mg oral dose of Oraglutide™ produced a sustained fall in glucose. Measuring 14% at Day 6 (p=.046), the longest duration presented from a single oral GLP-1 dose in a human IVGTT study. 28% increase in insulin secretion: Relative to placebo, insulin percent AUC increased by 12% day 0, (p=0.02) & 28% Day 1 (p = 0.025). Novel intestinal depot effect: Blood levels of semaglutide were higher on Day 1 than dosing on Day 0, consistent with lipid associated depot effect in the intestinal wall, a fundamentally new pharmacological finding. No nausea or side effects observed: No adverse events observed across the 8-subject cohort over one week, cons

Cardiolife Partners with Bhutan Ministry of Health to Strengthen Nationwide Cardiac Care8.6.2026 11:00:00 EEST | Press release

Cardiolife is proud to partner with the Ministry of Health of Bhutan to roll out its advanced AI-powered ECG diagnostics system nationwide. The collaboration will provide access to early ECG diagnosis and prevention, marking a major step forward in the country’s effort to strengthen heart health and preventive care. Bhutan has a population of just over 700,000 people and heart failure and other cardiac conditionsare among the leading causes of death. Following constructive meetings in Thimphu, His Excellency, the Health Minister, officially endorsed the national rollout of Cardiolife’s solution and expressed appreciation for Cardiolife’s commitment to advancing cardiac care through the provision of free software and ECG equipment in Bhutan. “We are grateful to the Cardiolife team for their commitment to improving heart health in Bhutan. With cardiovascular diseases on the rise, this collaboration marks an important milestone in our journey to strengthen early detection and prevention a

Reply at VivaTech 2026: Making AI, Agents and Robotics Happen Across the Enterprise8.6.2026 11:00:00 EEST | Press release

Reply[EXM, STAR: REY] is taking part in VivaTech 2026, Europe's largest innovation and technology event, held from June 17 to 20 at Paris Expo Porte de Versailles. At the event, Reply will showcase its latest innovations around AI for software engineering, AI-powered experiences, data and AI, and industrial AI. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608667672/en/ At VivaTech 2026 Reply will showcase its latest innovations around AI for software engineering, AI-powered experiences, data and AI, and industrial AI. Industries are being reshaped by AI, autonomous agents, robotics and new digital experiences. From strategy to execution, Reply helps companies move beyond experimentation and innovative ideas into concrete business value. Visitors can meet Reply in Hall 7.1, booth 1G12, and explore how, through real use cases, scalable solutions and live demonstrations, the group makes innovation happen. This year, Reply'

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye